CVT 0.00% $1.12 comvita limited ordinary shares

Ann: DIRECTOR: CVT: Comvita Director Resignation

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. lightbulb Created with Sketch. 2
    					CVT                                                                           
    26/04/2016 11:25                                                              
    DIRECTOR                                                                      
    NOT PRICE SENSITIVE                                                           
    REL: 1125 HRS Comvita Limited                                                 
                                                                                  
    DIRECTOR: CVT: Comvita Director Resignation                                   
                                                                                  
    Edward (Ed) Quilty has tendered his resignation from the Board of Comvita     
    Limited, effective immediately.                                               
                                                                                  
    Ed was first appointed to be a director of Comvita Limited when Derma         
    Sciences, Inc., Comvita's USA based woundcare partner, became a significant   
    shareholder in Comvita in August 2013.                                        
                                                                                  
    Ed resigned as the Chief Executive Officer of Derma at the end of 2015.  With 
    his resignation from Derma in the US, it was agreed by the Comvita Board that 
    it was no longer appropriate for Ed to continue as a director on the Comvita  
    Board.                                                                        
                                                                                  
    The Board is grateful to Ed for his contribution, particularly as it related  
    to keeping an ongoing strong relationship with Derma.  Sales of Medihoney     
    branded woundcare products by Derma to hospitals and professionals now        
    account for circa US$20m per annum and growing, realising a continuing        
    royalty stream for Comvita.                                                   
                                                                                  
    Ends                                                                          
                                                                                  
    For further information:                                                      
    Scott Coulter, Comvita CEO, 021 386 988                                       
    Neil Craig, Comvita Chairman, 021 731 509                                     
    Julie Chadwick, Comvita Communications Manager, 021 510 693                   
                                                                                  
    Background information                                                        
    About Comvita (www.comvita.com)                                               
    Comvita (NZX:CVT) is a global natural health company committed to the         
    development of innovative products, backed by ongoing investment in           
    scientific research.                                                          
    End CA:00281316 For:CVT    Type:DIRECTOR   Time:2016-04-26 11:25:28           				
 
watchlist Created with Sketch. Add CVT (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.